Price (delayed)
$0.86
Market cap
$2.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$7
Enterprise value
-$8.66M
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium
There are no recent dividends present for FRTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.